Cargando…

Amphotericin-B-liposomal/dexamethasone/methylprednisolone: Invasive candida kefyr infection, off label use and drug resistance: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831153/ http://dx.doi.org/10.1007/s40278-022-09812-z

Ejemplares similares

Colonization of the bovine uterus by Candida kefyr
por: Karstrup, Cecilia Christensen, et al.
Publicado: (2017)

Cutaneous candidiasis caused by Candida kefyr
por: Nurdin, Rosani Sri Camelia, et al.
Publicado: (2021)

Candida kefyr in Kuwait: Prevalence, antifungal drug susceptibility and genotypic heterogeneity
por: Ahmad, Suhail, et al.
Publicado: (2020)

An Unusual Case of Candida kefyr Fungemia in an Immunocompromised Patient
por: Jyothi, Lakshmi, et al.
Publicado: (2021)

Dexamethasone/hydrocortisone/methylprednisolone: Disseminated cryptococcosis following off label use of dexamethasone, hydrocortisone and methylprednisolone: case report
Publicado: (2022)

Molecular Characterization and Sterol Profiles Identify Nonsynonymous Mutations in ERG2 as a Major Mechanism Conferring Reduced Susceptibility to Amphotericin B in Candida kefyr
por: Asadzadeh, Mohammad, et al.
Publicado: (2023)

Candidiasis caused by Candida kefyr in a neonate: Case report
por: Weichert, Stefan, et al.
Publicado: (2012)

Dexamethasone/methylprednisolone: Off label use and lack of efficacy: case report
Publicado: (2022)

Dexamethasone/methylprednisolone: Off-label use and cryptococcal meningoencephalitis: case report
Publicado: (2022)

Dexamethasone: Off label treatment and Candida parapsilosis infection
Publicado: (2021)

Azithromycin/dexamethasone/methylprednisolone: Aspergillosis, mucormycosis and off-label use: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/remdesivir: Off-label use and lack of efficacy: case report
Publicado: (2021)

Amphotericin-B-liposomal/antibacterials/immunosuppressants: Various infections, nephrotoxicity and off-label use: 4 case reports
Publicado: (2022)

Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B
por: Toprak, Demet, et al.
Publicado: (2015)

Dexamethasone/methylprednisolone: Sino-orbital mucormycosis infection following off label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities following off label use: 21 case reports
Publicado: (2022)

Dexamethasone/methylprednisolone: Osteonecrosis of the knee following off-label use: 2 case reports
Publicado: (2022)

Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature
por: Spiliopoulou, Anastasia, et al.
Publicado: (2022)

Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.
por: Rodrigues, Célia F., et al.
Publicado: (2017)

Multiple Intravitreal Liposomal Amphotericin B for a Case of Candida glabrata Endophthalmitis
por: Sakai, Daiki, et al.
Publicado: (2021)

Liposomal amphotericin B—the present
por: Maertens, J, et al.
Publicado: (2022)

Liposomal amphotericin B—the past
por: Brüggemann, R J, et al.
Publicado: (2022)

Liposomal amphotericin B—the future
por: Hoenigl, M, et al.
Publicado: (2022)

Dexamethasone/methylprednisolone/prednisolone: Avascular necrosis following off-label use:3 case reports
Publicado: (2021)

Dexamethasone/enoxaparin-sodium/methylprednisolone: Occipital lobe haemorrhages and off-label use: case report
Publicado: (2021)

Dexamethasone/methylprednisolone/tocilizumab: Fatal disseminated mucormycosis following off-label use: case report
Publicado: (2022)

Dexamethasone/methylprednisolone/prednisolone: Rhino-orbital-cerebral mucormycosis and off-label use: 5 case reports
Publicado: (2021)

Dexamethasone/favipiravir/methylprednisolone: Hyperglycaemia, masking of cytokine storm and off-label use: 2 case reports
Publicado: (2021)

Liposomal Amphotericin B Treatment and the Leishmaniases
por: Berman, Jonathan
Publicado: (2019)

Amphotericin-B/amphotericin-B-liposomal: Lack of efficacy: 2 case reports
Publicado: (2022)

Prevalence and species distribution of Candida bloodstream infection in children and adults in two teaching university hospitals in Egypt: first report of Candida kefyr
por: Reda, Nashwa Mohamed, et al.
Publicado: (2022)

Successful therapy of Candida pulcherrima fungemia in a premature newborn with liposomal amphotericin B and micafungin
por: Mpakosi, Alexandra, et al.
Publicado: (2016)

In vitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest
por: Lovero, Grazia, et al.
Publicado: (2017)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Amphotericin-B-liposomal: No improvement: case report
Publicado: (2022)

Amphotericin-B-liposomal: Anaphylaxis: case report
Publicado: (2022)

Antimicrobial activity of coconut oil-in-water emulsion on Staphylococcus epidermidis and Escherichia coli EPEC associated to Candida kefyr
por: de Oliveira, Susy Ferraz, et al.
Publicado: (2018)

First case of Kluyveromyces marxianus (Candida kefyr) late onset keratitis after lamellar endothelial corneal graft
por: Aldejohann, Alexander M., et al.
Publicado: (2021)

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
por: Miceli, Marisa H, et al.
Publicado: (2012)

Dexamethasone: Candida albicans endogenous endophthalmitis due to off-label use: case report
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hjvm527510uue1jqs8b8t8hrr8